<DOC>
	<DOCNO>NCT00738660</DOCNO>
	<brief_summary>Hypothesis : The angiotensin receptor blocker telmisartan effective reduction albumin excretion rate ( AER ) patient type1 diabetes micro macroalbuminuria . Dual blockade addition ramipril angiotensin receptor blocker give add efficacy reduction AER . ARB telmisartan give 24 hr BP lower effect . Summary : This open label cross study involve 30 patient initially treat Telmisartan 80 mg eight week follow addition Ramipril 10 mg eight week . Albuminuria reduction BP reduction clinic ambulatory BP record study end phase .</brief_summary>
	<brief_title>Efficacy Telmisartan Combination Telmisartan Ramipril type1 Diabetes Patients With Nephropathy</brief_title>
	<detailed_description>To evaluate antialbuminuric efficacy angiotensin receptor blocker ( ARB ) telmisartan combination telmisartan ramipril patient type1 DM either micro macroalbuminuria.To evaluate drug antihypertensive efficacy influence dip pattern use ambulatory BP monitoring . Methods : Open label cross study involve 30 patient initially treat telmisartan 80 mg eight week follow addition ramipril 10 mg eight week . Albuminuria reduction BP reduction clinic ambulatory BP record study end phase Overnight urine sample nine hour duration collect . The volume urine verified measurement jar accuracy 50ml study investigator every occasion . . Albuminuria estimate immuno-turbidimetry Hemocue albumin system Angelholm AD , Sweden ( inter assay CV 4.3 % ) . The albumin excretion rate ( AER ) baseline evaluation determine mean AER positive urine sample . During subsequent evaluation end 8weeks end 16 week mean albumin excretion rate two successive overnight urine sample take mean .Ambulatory BP ( ABP ) measurement : ABP measure use Spacelabs device 90207 Spacelabs inc. use describe ( 14 ) .A uniform protocol inflation every 30 min use . Cuff apply nondominant arm . Recordings start patient seven ten AM .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>Diabetes mellitus ADA criterion Clinical history DKA HbA1C &lt; 7.5 , urine AER &gt; /= 20 mcg/min two overnight urine sample Pregnancy Unwillingness use contraception time study Creatinine &gt; 3 mg/dl Suspected/proven non diabetic nephropathy Active urinary sediment</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>type1 DM</keyword>
	<keyword>microalbuminuria</keyword>
	<keyword>nephropathy</keyword>
	<keyword>albumin excretion rate</keyword>
	<keyword>dual blockade</keyword>
	<keyword>ACEI</keyword>
	<keyword>ARB</keyword>
</DOC>